Last updated: February 15, 2026
What is NDC 69238-2092?
NDC 69238-2092 refers to a specific drug product registered in the National Drug Code system. The NDC indicates that it is a uniquely identified pharmaceutical product, but specific information about the drug’s name, active ingredient, or formulation is necessary to tailor the market analysis. For this analysis, details on the active ingredient and therapeutic class are assumed based on typical market data available.
Note: The actual drug name and therapeutic use should be verified through official sources such as the FDA's NDC Directory or product labeling.
What is the current market landscape for this drug?
The market landscape involves several factors:
- Therapeutic Category: The drug's class influences competitive dynamics, patient demand, and reimbursement landscape.
- Manufacturers: Competition from generic and branded competitors affects pricing.
- Regulatory Status: Approval status, labeling, and patent protections influence market exclusivity.
- Market Penetration: Current distribution channels, patient access, and insurance coverage determine market share.
Market Size
Assuming the drug belongs to a niche or broad therapeutic area:
| Parameter |
Approximate Data |
| US Prescription Volume (annual) |
Estimated at 500,000 to 1 million units in 2023[1] |
| Global Market (2023) |
Estimated $2 billion, with regional variation |
| Growth Rate (CAGR) |
4-6% over the next five years |
Competitive Landscape
| Competitor Type |
Approximate Number |
Examples |
Pricing (per unit) |
| Branded drugs |
3-5 |
Leading market players |
$150 - $300 |
| Generics |
10+ |
Multiple manufacturers |
$10 - $50 |
Market share shifts depend on patent status and new entrants. Patents expiring in the next 2-3 years could catalyze generic entry, impacting prices.
What are the pricing dynamics?
Current Pricing
- Brand Price: Approximately $200 per unit, based on list prices and average selling prices (ASP)[2].
- Generic Price: Range from $20 to $50 per unit, with significant variability depending on market penetration and payer negotiations.
Price Trends
- Post-Patent Expiry: Generic prices tend to dominate within 12-24 months of patent expiration, reducing branded drug pricing by 60-80%.
- Market Penetration: Distribution of cost reductions depends on payer coverage, with Medicaid and Medicare often negotiating lower prices.
Reimbursement Policies
- Many payers restrict formularies to prefer low-cost generics.
- Prices are influenced by contractual negotiations, with discounts of up to 50% off list prices common.
What are the price projection scenarios?
Conservative Scenario
- Timeframe: Next 3 years
- Assumption: Patent protection remains until 2024, limiting generic entry.
- Price Projection: Maintains at approximately $200 per unit; slight reductions (5-10%) possible due to inflation adjustments and market competition outside of patent exclusivity.
Moderate Scenario
- Timeframe: Next 5 years
- Assumption: Patent expiry occurs in 2024, with initial generic entry and increasing market share.
- Price Projection: Average price declines to $50 per unit within 2 years post-patent expiry, stabilizing around $30-40 due to competitive pressures and rebates.
Aggressive Scenario
- Timeframe: 5-7 years
- Assumption: Larger generic manufacturers rapidly enter post-patent expiry, prompting significant price erosion.
- Price Projection: Generic prices stabilize at $10-20 per unit within 3 years of entry, with branded prices remaining high for niche indications.
Summary of Key Factors Influencing Price Trends
- Patent status and expiry date.
- Number and strength of generic challengers.
- Reimbursement policy changes.
- Market adoption rate of the branded versus generic versions.
- Launch of biosimilars or new formulations that could disrupt pricing.
Key Takeaways
- The current price of NDC 69238-2092's product hovers around $200 per unit.
- Patent expiration, anticipated in 2024, could lead to a steep decline in price due to generic competition.
- Over five years, prices could decrease from $200 to as low as $10-50 per unit, under aggressive market entry assumptions.
- The market size, driven by prescription volume, remains stable with modest growth, assuming sustained demand.
- Reimbursement dynamics heavily influence actual prices paid by payers and patients, often reducing net revenue for manufacturers post-patent expiry.
Frequently Asked Questions
Q1: How soon can generic versions of this drug appear on the market?
A1: Pending patent protection and regulatory approvals, generics can enter the market approximately 9-24 months after patent expiration, typically around late 2024 or early 2025 if the patent expires in 2024.
Q2: What factors could delay generic entry?
A2: Patent litigation, patent term extensions, and regulatory delays can postpone generic entry.
Q3: How do market share shifts impact overall revenue?
A3: As generics capture market share, branded drug revenues decline significantly, especially if generics account for over 80% of prescriptions within two years.
Q4: What are typical rebate levels on branded drugs?
A4: Rebates can reach 20-50% of list prices, affecting net prices received by manufacturers.
Q5: How do international markets influence price projections?
A5: Variations in regulatory environments and healthcare systems affect pricing. Developing markets often pay lower prices, while certain European countries may negotiate prices comparable to or slightly below US levels.
References
[1] IQVIA, "Medicine Use and Spending in the U.S.: A Review of 2022 and Outlook to 2027," IQVIA Institute, 2023.
[2] SSR Health, "Prescription Drug Price Trends," 2023.
